BioNTech
WEBWe are committed to improving the health of people worldwide with our fundamental research and development of immunotherapies. We believe in scientific rigor, innovation and passion as driving force. BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental …
BioNTech - Wikipedia
WEBBioNTech SE (/ b iː ˈ ɒ n t ɛ k / bee-ON-tek; or / b aɪ ˈ ɒ n t ɛ k / bye-ON-tek [2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.
BioNTech US
WEBA transatlantic leader in individualized neoantigen-targeted T cell therapies. Based in Cambridge, MA, BioNTech US serves as BioNTech’s North American headquarters and is an important part of our global effort to pioneer the development of next-generation immuno-oncology therapies.
The Road to a New Era of Immunotherapy - BioNTech
WEBBioNTech was founded on the idea of using mRNA to activate the immune system against a patient’s individual tumor – an approach that we believe can also be tailored to target several kinds of diseases. Through our groundbreaking R&D efforts, we have become a pioneer in many ways:
Pfizer and BioNTech Announce Further Details on …
WEBApr 9, 2020 · Biopharmaceutical New Technologies (BioNTech) is a next generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and rare diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals.
Welcome to our investor page | BioNTech
WEBAug 5, 2024 · Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals.
BioNTech | Company Overview & News - Forbes
WEBBioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about 17% over the ...
Jefferies upgrades BioNTech SE (BNTX) to a Buy - Markets Insider
WEB5 days ago · Jefferies analyst Akash Tewari upgraded BioNTech SE (BNTX – Research Report) to a Buy today and set a price target of $150.00. The company’s shares closed yesterday at $123.47. The company’s ...
The Husband-and-Wife Team Behind the Leading Vaccine to …
WEBNov 10, 2020 · The German company BioNTech, founded by two scientists, has teamed up with Pfizer on a vaccine that was found to be more than 90 percent effective.
Shot of a Lifetime: How Pfizer and BioNTech Developed and …
WEBBioNTech, a German immunotherapy company, had pioneered a new genetic technology that uses a wisp of genetic code from a virus—called messenger RNA—to prompt cells to make antibodies that fight off that virus 4.